bortezomib will increase the degree or influence of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Improved flibanserin adverse consequences may take place if coadministered with several weak CYP3A4 inhibitors.lenacapavir will raise the amount or outcome of bortezomib by impacting hepatic/intestinal enzym